Search filters

List of works by Angela Coliva

(177)Lu- labeled MOv18 as compared to (131)I- or (90)Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts.

scientific article

90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas

scientific article published on 31 May 2005

A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer.

scientific article published on 20 February 2013

Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin's lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin).

scientific article

Antitumor Effects of a Human Dimeric Antibody Fragment 131I-AFRA-DFM5.3 in a Mouse Model for Ovarian Cancer ⬇️

scientific article published on November 8, 2011

Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results.

scientific article published in February 2007

Evaluation of circulating calcitonin: analytical aspects.

scientific article published in September 2003

Shed HER2 extracellular domain in HER2-mediated tumor growth and in trastuzumab susceptibility

scientific article

Synthesis optimization of 2-(4-N-[11C]methylaminophenyl)-6-hydroxybenzothiazole ([11C]PIB), β-amyloid PET imaging tracer for Alzheimer's disease diagnosis

scientific article published on 17 July 2015

Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy

scientific article published on 01 February 2014

Paulina is supported by:

About Paulina

Help